IDIOPATHIC ANAPHYLAXIS
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Idiopathic anaphylaxis (IA) is a diagnosis of exclusion, made after a comprehensive allergic evaluation has ruled out all other causes of anaphylaxis. Idiopathic anaphylaxis is characterized by sudden and severe symptoms affecting the skin, respiratory, circulatory, gastrointestinal, and neurological systems. Although the pathogenesis is not clearly understood, factors such as mast cells having a lower mediator release threshold, high levels of activated lymphocytes, altered gastrointestinal permeability, and ge-netic predisposition have been identified. There are clinical conditions that are not related to mediator release from mast cells and basophils or that can mimic anaphylaxis. These must be ruled out before a diagnosis of IA is made. Before diagnosing IA, it is necessary to investigate potentially overlooked or difficult-to-identify allergens. Taking a detailed medical history is crucial here. The main goal of this comprehensive approach is to minimize the risk of a false-negative IA diagnosis and ensure accu-rate patient classification. Hidden allergens, especially cross-reactions or contaminations in foods, and co-factors leading to anaphylaxis should also be thoroughly evaluated. Rapid management of acute attacks and prevention of future reactions are the most important aspects of patient management. In acute attacks, immediate epinephrine administration at the onset of symptoms is essential. Epinephrine is the first-line, life-saving treatment for anaphylaxis. Patients should have at least 2 epinephrine au-to-injectors that they can self-administer and receive detailed training on when and how to use them. Prophylactic treatment is indicated for patients with frequently recurring IA (≥6 attacks per year or ≥2 attacks in 2 months). Long-term treatment is determined by the frequency and severity of the patient's symptoms, and daily antihistamines and corticosteroids are commonly used for prophylaxis. The prog-nosis for IA is generally favorable. However, the unpredictable nature of the disease causes anxiety and uncertainty for patients, negatively impacting their daily lives and even their work, thus reducing their quality of life. For these reasons, re-evaluation of exclusion diagnoses and detailed history taking are necessary at each attack. Personalized treatment and monitoring methods should be developed. Research is crucial to understand the pathophysiology of IA better, develop more reliable biomarkers, and establish evidence-based guidelines for the dosage and duration of prophylaxis treatment. Keywords: Idiopathic anaphylaxis; Epinephrine; Long-term prophylaxis
Fields of Study & Subjects
Food Allergy and Anaphylaxis Research
Mast cells and histamine
Drug-Induced Adverse Reactions
Publication details
- Journal / source
- Turkiye Klinikleri eBooks
- Pages
- 297–308
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Book chapter